The Disease 190 Million Women Have and Doctors Take a Decade to Diagnose
Some numbers are so large they become abstractions the moment you read them. 190 million is one of those numbers, and yet it’s the World Health Organization’s own estimate for how many women and girls worldwide currently live with endometriosis, a chronic inflammatory condition in which tissue similar to the uterine lining grows outside the uterus, causing pain, inflammation, and in many cases, infertility. That’s roughly 1 in 10 women of reproductive age. And despite that staggering prevalence, the average time between a woman first noticing symptoms and actually receiving a diagnosis remains somewhere between 4 and 11 years, depending on the country.
This isn’t a rare disease slipping through the cracks of an overburdened system. It’s one of the most common gynecological conditions on earth, and it is still, remarkably, treated as a diagnostic afterthought.
The Diagnostic Delay Is Not Improving as Fast as You’d Expect
A large prospective cohort study published in the Journal of Women’s Health in early 2026 found that women with endometriosis or adenomyosis, a related condition involving similar tissue growth within the uterine wall, faced an average diagnostic delay of a decade or more. A separate 2024 New Zealand survey found an average delay of 8.6 years. In the United States, the American College of Obstetricians and Gynecologists cites a range of 4 to 11 years from symptom onset to diagnosis, a range so wide it tells its own story about just how inconsistent recognition of this disease still is, even within a single healthcare system.
It’s worth sitting with what that delay actually means in practice. The median age of diagnosis is around 28, but symptoms typically begin six to ten years earlier, often between ages 14 and 21. That means a meaningful share of the people living with this condition spend the entirety of their adolescence experiencing symptoms with no name attached to them, frequently being told the pain they’re describing is simply a normal part of having a period.
Why the Delay Happens: It’s Structural, Not Just a Communication Gap
Part of the challenge is genuinely clinical. For decades, definitive diagnosis required laparoscopic surgery, an invasive procedure that isn’t offered lightly or early. But research into diagnostic delay has consistently found that the causes go well beyond the need for surgical confirmation. A 2025 systematic review examining the factors behind delayed diagnosis found that normalization of menstrual pain, both by patients themselves and by the clinicians they consulted, was a recurring, significant driver of delay across the studies analyzed.
This has begun to shift, at least on paper. ACOG published its first-ever clinical guidance on endometriosis diagnosis in February 2026, recommending that providers use symptom-based assessment to reach a presumptive diagnosis rather than requiring surgical confirmation before treatment can begin, a genuinely significant change aimed directly at cutting down years of delay.
The Symptom Burden Is Severe, Not Subtle
One persistent misconception is that endometriosis presents as mild, easily dismissed discomfort. The data tells a very different story. Research aggregating global statistics found that 70 to 80 percent of people with endometriosis experience chronic pelvic pain that isn’t relieved by over-the-counter medication, 85 percent report pain during menstruation severe enough to be clinically notable, and 60 percent report pain during intercourse. Roughly 40 percent describe pain severe enough to interfere directly with work, school, or daily functioning.
Fertility impact is significant as well. Between 30 and 50 percent of women with endometriosis experience difficulty conceiving, and the condition is present in an estimated 25 to 50 percent of women being evaluated specifically for infertility, a strong enough association that fertility specialists now consider endometriosis a standard differential when investigating unexplained infertility.
Diagnosis Rates Are Rising, Which Is a Complicated Kind of Good News
Data from Epic Research, drawn from an analysis of 25 million patient records, found that endometriosis diagnosis rates in the United States rose 32 percent between 2017 and 2024, climbing from 24.9 to 32.8 diagnoses per 10,000 patients. Diagnoses are highest among women aged 35 to 49, and among patients diagnosed in 2024, over 55 percent had documented abdominal or pelvic pain in their records within the two years prior, the single most common symptom preceding diagnosis.
Rising diagnosis rates are, in one sense, genuinely encouraging, they likely reflect growing clinical awareness and reduced stigma around the condition. But researchers are careful to note this doesn’t necessarily mean the disease itself is becoming more common, it more plausibly reflects a system that is finally starting to catch cases it was previously missing entirely.
The Gap Isn’t Even Across Everyone Affected
Diagnostic delay isn’t distributed equally. Research has found that Black women in the United States are diagnosed an average of 2.5 years later than white women, a disparity researchers attribute to delayed recognition of symptoms in clinical settings, not to any difference in how the disease itself presents. Broader statistics on prevalence face a related distortion, figures on the lower end of published ranges frequently exclude transgender, gender-fluid, and nonbinary people entirely, and one landmark study found prevalence as high as 25 percent within that population specifically, a figure far above the general estimate, suggesting the true scale of underdiagnosis may be even larger than the headline numbers already convey.
The Funding Gap Behind the Diagnostic Gap
It’s difficult to separate how slowly this disease gets diagnosed from how little research funding it receives relative to its scale. In the United States, NIH funding for endometriosis research totaled roughly 28 million dollars in fiscal year 2024, compared to 3.1 billion dollars allocated to HIV/AIDS research in the same year, this despite endometriosis affecting more than five times as many Americans. It’s a genuinely uncomfortable comparison, and one that researchers studying the condition point to directly when explaining why diagnostic tools, treatment options, and clinical awareness have all lagged so far behind the disease’s actual prevalence.
What This Means If the Symptoms Sound Familiar
Persistent pelvic pain that disrupts daily life, pain during intercourse, heavy or irregular bleeding, and pain that doesn’t respond to standard over-the-counter treatment are not, according to the current body of research, simply things to push through. The updated 2026 clinical guidance exists precisely because so many cases were being delayed by the old standard of requiring surgical proof before pursuing treatment. If any of this sounds familiar, either in your own experience or someone else’s, it’s worth naming clearly and directly with a doctor, symptom by symptom, rather than folding it quietly into the general, unspoken category of “periods are just hard.”
The Bottom Line
190 million people living with a condition, an average diagnostic delay measured in years rather than weeks, and a research funding gap that doesn’t remotely reflect the disease’s actual reach. Endometriosis isn’t underdiagnosed because it’s rare or because its symptoms are subtle. It’s underdiagnosed because, for decades, a disease this common was treated as an exception rather than something the medical system should have been looking for all along.
